U.S. bans entry for travelers from Ebola-affected countries
-
By
-
Annalisa Merelli
-
May 18, 2026
By
Annalisa Merelli
May 18, 2026
June 5, 2026
Phase 3 ENHANCE-1 results showed higher composite clinical cure and microbiologic response rates with cefepime-zidebactam vs meropenem in hospitalized adults with complicated urinary tract infection or acute pyelonephritis.
June 3, 2026